Reaction #436741

ord-00966f5951e14feea7101aeed20cc7de

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    OtherThe reaction mixture was purified by preparative HPLC utilizing ODS column
  2. 2
    workup.ADDITIONThe eluate containing a desired product
  3. 3
    Concentrationwas concentrated to about 30 ml in vacuo
  4. 4
    Otherchromatographed on Diaion®
  5. 5
    Wash(Mitsubishi Chemical Corporation) eluting with 30% aqueous 2-propanol
  6. 6
    ConcentrationThe eluate was concentrated to about 30 ml in vacuo

Procedure

A solution of 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-[3-(formamidomethyl)-4,5,6,7-tetrahydro-1-pyrazolo[1,5-a]pyrimidinio]methyl-3-cephem-4-carboxylate (130 mg) in 10% aqueous hydrochloric acid (4.36 ml) was stirred at room temperature for 6 hours. The reaction mixture was purified by preparative HPLC utilizing ODS column. The eluate containing a desired product was concentrated to about 30 ml in vacuo. The concentrate was adjusted to about pH 3 with concentrated hydrochloric acid and chromatographed on Diaion® HP-20 (Mitsubishi Chemical Corporation) eluting with 30% aqueous 2-propanol. The eluate was concentrated to about 30 ml in vacuo and lyophilized to give 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-(3-aminomethyl-4,5,6,7-tetrahydro-1-pyrazolo[1,5-a]pyrimidinio)methyl-3-cephem-4-carboxylate (48 mg) as an amorphous solid.

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07179801B2uspto-grants-2007_02